Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Creative Medical Technology Holdings (CELZ) Operating Margin (2017 - 2025)

Historic Operating Margin for Creative Medical Technology Holdings (CELZ) over the last 9 years, with Q1 2025 value amounting to 55349.27%.

  • Creative Medical Technology Holdings' Operating Margin changed N/A to 55349.27% in Q1 2025 from the same period last year, while for Sep 2025 it was 101379.43%, marking a year-over-year decrease of 501979200.0%. This contributed to the annual value of 52216.92% for FY2024, which is 102289900.0% up from last year.
  • Creative Medical Technology Holdings' Operating Margin amounted to 55349.27% in Q1 2025.
  • In the past 5 years, Creative Medical Technology Holdings' Operating Margin registered a high of 1855.31% during Q3 2022, and its lowest value of 62857.8% during Q4 2024.
  • Moreover, its 5-year median value for Operating Margin was 20316.32% (2024), whereas its average is 25661.6%.
  • Within the past 5 years, the most significant YoY rise in Creative Medical Technology Holdings' Operating Margin was 64790500bps (2022), while the steepest drop was -315787100bps (2022).
  • Quarter analysis of 5 years shows Creative Medical Technology Holdings' Operating Margin stood at 2173.64% in 2021, then crashed by -1453bps to 33752.35% in 2022, then plummeted by -75bps to 59061.3% in 2023, then fell by -6bps to 62857.8% in 2024, then grew by 12bps to 55349.27% in 2025.
  • Its Operating Margin was 55349.27% in Q1 2025, compared to 62857.8% in Q4 2024 and 20316.32% in Q2 2024.